CL2010001424A1 -
Compounds derived from azacarbolines; intermediate compounds; pharmaceutical composition; preparation procedure; and its use in the treatment of cancer.
- Google Patents
Compounds derived from azacarbolines; intermediate compounds; pharmaceutical composition; preparation procedure; and its use in the treatment of cancer.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi AventisfiledCriticalSanofi Aventis
Publication of CL2010001424A1publicationCriticalpatent/CL2010001424A1/en
Compuestos derivados de azacarbolinas; compuestos intermediarios; composición farmacéutica; procedimiento de preparación; y su uso en el tratamiento del cáncer.Compounds derived from azacarbolines; intermediate compounds; pharmaceutical composition; preparation procedure; and its use in the treatment of cancer.
CL2010001424A2008-06-122010-12-10
Compounds derived from azacarbolines; intermediate compounds; pharmaceutical composition; preparation procedure; and its use in the treatment of cancer.
CL2010001424A1
(en)
Compounds derived from azacarbolines; intermediate compounds; pharmaceutical composition; preparation procedure; and its use in the treatment of cancer.
Compounds derived from substituted phenylamino-benzene; Preparation method; pharmaceutical composition; farm kit; and use of said compounds in the treatment of cancer.
COMPOUNDS DERIVED FROM REPLACED HETEROPENTACICLOS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER.
Fused heterocyclic compounds derived from pyrimidinones, potent inhibitors of cdc7; pharmaceutical composition; and its use in the prevention or treatment of cancer.
Compounds derived from substituted carboxyamide heterocycles, ar antagonist; pharmaceutical composition comprising them; and use in the treatment of prostate cancer.
Compounds derived from 2,7-naphthyridines-1-one, mediators of syk; pharmaceutical composition; and use in the treatment of inflammatory, respiratory, cellular proliferative or autoimmune disease.
Compounds derived from thiazolidinediones and substituted oxazolidinediones; pharmaceutical composition; process of preparation of the pharmaceutical composition; and use in the treatment of diseases such as rheumatoid arthritis, epoc, cancer, among others.
Substituted triazine-derived compounds, mediated by inhibition of p13 and mtor kinase; pharmaceutical composition; preparation procedure; and its use in the treatment of different types of cancer.
Compounds derived from imidazo [1,2-a] pyridine; preparation procedure; pharmaceutical composition; intermediate compounds; and use in the treatment of cancer.
Bicyclic compounds of pyrazinone; preparation procedure; pharmaceutical composition; kit; and use in the treatment and / or prevention of cardiovascular diseases, cancer, among others.
Compounds derived from triazolo [4,3-a] pyridine; preparation procedure; pharmaceutical composition; and use in the treatment of diseases such as cancer.